The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global HIV Diagnostics Market Research Report 2025

Global HIV Diagnostics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713693

No of Pages : 110

Ask Your Query

Synopsis

The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.

Global HIV Diagnostics market is projected to reach US$ 4697.7 million in 2029, increasing from US$ 2636.2 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole HIV Diagnostics market research.

Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global HIV Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List):

  •     Abbott
  •     Abbott Healthcare
  •     Abbvie Inc.
  •     Brsitol-Myers Squibb
  •     Janssen Therapeutics
  •     Gilead Sciences
  •     Merck & Co. Inc
  •     VIIV Healthcare
  •     BD Biosciences
  •     Beckman Coulter
  •     Partec
  •     Sysmex
  •     Apogee Flow Systems
  •     PointCare Technologies Inc.
  •     Zyomyx Inc.
  •     Mylan inc.
  •     Roche Diagnostics
  •     Siemens Healthcare
  •     Qiagen
  •     BioMerieux

Segment by Type

  •     Consumables
  •     Assay, Kits and Reagents
  •     Other Consumables
  •     Instruments
  •     Software and Services

Segment by Application

  •     Antibody Tests
  •     Viral Load Tests
  •     CD4 Tests
  •     Tests for Early Infant Diagnosis
  •     Tests for Viral Identification

By Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

 

The HIV Diagnostics report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

 

1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Consumables
        1.2.3 Assay, Kits and Reagents
        1.2.4 Other Consumables
        1.2.5 Instruments
        1.2.6 Software and Services
    1.3 Market by Application
        1.3.1 Global HIV Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Antibody Tests
        1.3.3 Viral Load Tests
        1.3.4 CD4 Tests
        1.3.5 Tests for Early Infant Diagnosis
        1.3.6 Tests for Viral Identification
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global HIV Diagnostics Market Perspective (2018-2029)
    2.2 HIV Diagnostics Growth Trends by Region
        2.2.1 Global HIV Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 HIV Diagnostics Historic Market Size by Region (2018-2023)
        2.2.3 HIV Diagnostics Forecasted Market Size by Region (2024-2029)
    2.3 HIV Diagnostics Market Dynamics
        2.3.1 HIV Diagnostics Industry Trends
        2.3.2 HIV Diagnostics Market Drivers
        2.3.3 HIV Diagnostics Market Challenges
        2.3.4 HIV Diagnostics Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top HIV Diagnostics Players by Revenue
        3.1.1 Global Top HIV Diagnostics Players by Revenue (2018-2023)
        3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2018-2023)
    3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by HIV Diagnostics Revenue
    3.4 Global HIV Diagnostics Market Concentration Ratio
        3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2022
    3.5 HIV Diagnostics Key Players Head office and Area Served
    3.6 Key Players HIV Diagnostics Product Solution and Service
    3.7 Date of Enter into HIV Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 HIV Diagnostics Breakdown Data by Type
    4.1 Global HIV Diagnostics Historic Market Size by Type (2018-2023)
    4.2 Global HIV Diagnostics Forecasted Market Size by Type (2024-2029)

 5 HIV Diagnostics Breakdown Data by Application
    5.1 Global HIV Diagnostics Historic Market Size by Application (2018-2023)
    5.2 Global HIV Diagnostics Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America HIV Diagnostics Market Size (2018-2029)
    6.2 North America HIV Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America HIV Diagnostics Market Size by Country (2018-2023)
    6.4 North America HIV Diagnostics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe HIV Diagnostics Market Size (2018-2029)
    7.2 Europe HIV Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe HIV Diagnostics Market Size by Country (2018-2023)
    7.4 Europe HIV Diagnostics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific HIV Diagnostics Market Size (2018-2029)
    8.2 Asia-Pacific HIV Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific HIV Diagnostics Market Size by Region (2018-2023)
    8.4 Asia-Pacific HIV Diagnostics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America HIV Diagnostics Market Size (2018-2029)
    9.2 Latin America HIV Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America HIV Diagnostics Market Size by Country (2018-2023)
    9.4 Latin America HIV Diagnostics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa HIV Diagnostics Market Size (2018-2029)
    10.2 Middle East & Africa HIV Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa HIV Diagnostics Market Size by Country (2018-2023)
    10.4 Middle East & Africa HIV Diagnostics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Detail
        11.1.2 Abbott Business Overview
        11.1.3 Abbott HIV Diagnostics Introduction
        11.1.4 Abbott Revenue in HIV Diagnostics Business (2018-2023)
        11.1.5 Abbott Recent Development
    11.2 Abbott Healthcare
        11.2.1 Abbott Healthcare Company Detail
        11.2.2 Abbott Healthcare Business Overview
        11.2.3 Abbott Healthcare HIV Diagnostics Introduction
        11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2018-2023)
        11.2.5 Abbott Healthcare Recent Development
    11.3 Abbvie Inc.
        11.3.1 Abbvie Inc. Company Detail
        11.3.2 Abbvie Inc. Business Overview
        11.3.3 Abbvie Inc. HIV Diagnostics Introduction
        11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2018-2023)
        11.3.5 Abbvie Inc. Recent Development
    11.4 Brsitol-Myers Squibb
        11.4.1 Brsitol-Myers Squibb Company Detail
        11.4.2 Brsitol-Myers Squibb Business Overview
        11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction
        11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2018-2023)
        11.4.5 Brsitol-Myers Squibb Recent Development
    11.5 Janssen Therapeutics
        11.5.1 Janssen Therapeutics Company Detail
        11.5.2 Janssen Therapeutics Business Overview
        11.5.3 Janssen Therapeutics HIV Diagnostics Introduction
        11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2018-2023)
        11.5.5 Janssen Therapeutics Recent Development
    11.6 Gilead Sciences
        11.6.1 Gilead Sciences Company Detail
        11.6.2 Gilead Sciences Business Overview
        11.6.3 Gilead Sciences HIV Diagnostics Introduction
        11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2018-2023)
        11.6.5 Gilead Sciences Recent Development
    11.7 Merck & Co. Inc
        11.7.1 Merck & Co. Inc Company Detail
        11.7.2 Merck & Co. Inc Business Overview
        11.7.3 Merck & Co. Inc HIV Diagnostics Introduction
        11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2018-2023)
        11.7.5 Merck & Co. Inc Recent Development
    11.8 VIIV Healthcare
        11.8.1 VIIV Healthcare Company Detail
        11.8.2 VIIV Healthcare Business Overview
        11.8.3 VIIV Healthcare HIV Diagnostics Introduction
        11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2018-2023)
        11.8.5 VIIV Healthcare Recent Development
    11.9 BD Biosciences
        11.9.1 BD Biosciences Company Detail
        11.9.2 BD Biosciences Business Overview
        11.9.3 BD Biosciences HIV Diagnostics Introduction
        11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2018-2023)
        11.9.5 BD Biosciences Recent Development
    11.10 Beckman Coulter
        11.10.1 Beckman Coulter Company Detail
        11.10.2 Beckman Coulter Business Overview
        11.10.3 Beckman Coulter HIV Diagnostics Introduction
        11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2018-2023)
        11.10.5 Beckman Coulter Recent Development
    11.11 Partec
        11.11.1 Partec Company Detail
        11.11.2 Partec Business Overview
        11.11.3 Partec HIV Diagnostics Introduction
        11.11.4 Partec Revenue in HIV Diagnostics Business (2018-2023)
        11.11.5 Partec Recent Development
    11.12 Sysmex
        11.12.1 Sysmex Company Detail
        11.12.2 Sysmex Business Overview
        11.12.3 Sysmex HIV Diagnostics Introduction
        11.12.4 Sysmex Revenue in HIV Diagnostics Business (2018-2023)
        11.12.5 Sysmex Recent Development
    11.13 Apogee Flow Systems
        11.13.1 Apogee Flow Systems Company Detail
        11.13.2 Apogee Flow Systems Business Overview
        11.13.3 Apogee Flow Systems HIV Diagnostics Introduction
        11.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2018-2023)
        11.13.5 Apogee Flow Systems Recent Development
    11.14 PointCare Technologies Inc.
        11.14.1 PointCare Technologies Inc. Company Detail
        11.14.2 PointCare Technologies Inc. Business Overview
        11.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction
        11.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2018-2023)
        11.14.5 PointCare Technologies Inc. Recent Development
    11.15 Zyomyx Inc.
        11.15.1 Zyomyx Inc. Company Detail
        11.15.2 Zyomyx Inc. Business Overview
        11.15.3 Zyomyx Inc. HIV Diagnostics Introduction
        11.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2018-2023)
        11.15.5 Zyomyx Inc. Recent Development
    11.16 Mylan inc.
        11.16.1 Mylan inc. Company Detail
        11.16.2 Mylan inc. Business Overview
        11.16.3 Mylan inc. HIV Diagnostics Introduction
        11.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2018-2023)
        11.16.5 Mylan inc. Recent Development
    11.17 Roche Diagnostics
        11.17.1 Roche Diagnostics Company Detail
        11.17.2 Roche Diagnostics Business Overview
        11.17.3 Roche Diagnostics HIV Diagnostics Introduction
        11.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2018-2023)
        11.17.5 Roche Diagnostics Recent Development
    11.18 Siemens Healthcare
        11.18.1 Siemens Healthcare Company Detail
        11.18.2 Siemens Healthcare Business Overview
        11.18.3 Siemens Healthcare HIV Diagnostics Introduction
        11.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2018-2023)
        11.18.5 Siemens Healthcare Recent Development
    11.19 Qiagen
        11.19.1 Qiagen Company Detail
        11.19.2 Qiagen Business Overview
        11.19.3 Qiagen HIV Diagnostics Introduction
        11.19.4 Qiagen Revenue in HIV Diagnostics Business (2018-2023)
        11.19.5 Qiagen Recent Development
    11.20 BioMerieux
        11.20.1 BioMerieux Company Detail
        11.20.2 BioMerieux Business Overview
        11.20.3 BioMerieux HIV Diagnostics Introduction
        11.20.4 BioMerieux Revenue in HIV Diagnostics Business (2018-2023)
        11.20.5 BioMerieux Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock